June 12, 2024
The University of Cincinnati Cancer Center announced a street in Uptown Cincinnati has been renamed Healing Way in anticipation of the opening of the Blood Cancer Healing Center.
February 9, 2022
Precision and toughness have been engrained in the University of Cincinnati's Dr. Alicia Heelan from a young age, and her time as a Team USA figure skater has prepared her for her current work as a breast cancer surgeon.
June 4, 2022
The University of Cincinnati's Thomas Herzog, MD, is presenting a poster describing a new immunotherapy trial for platinum-resistant ovarian cancer, called ARTISTRY-7, at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
November 3, 2022
The University of Cincinnati's Trisha Wise-Draper, MD, PhD, is co-corresponding author of new research in JAMA Oncology that provides more clarity on how immunotherapy treatment for patients with cancer affects COVID-19 severity.
April 14, 2023
The University of Cincinnati Cancer Center's Melinda Butsch Kovacic and colleagues will present research abstracts on several community outreach and engagement initiatives at the American Association for Cancer Research Annual Meeting 2023, held in Orlando, Florida, April 14-19.
October 23, 2023
The American Cancer Society has awarded the University of Cincinnati Cancer Center a $360,000 Institutional Research Grant that will provide pilot grant support for early-stage investigators working in cancer-related fields.
January 25, 2022
The University of Cincinnati's Dr. Timothy Phoenix has received three separate grants from philanthropic organizations and the National Institutes of Health to learn more about the genetic workings of pediatric diffuse midline gliomas, a deadly brain tumor.
November 19, 2021
University of Cincinnati College of Pharmacy researchers have engineered a probiotic bacteria designed to break down cancer cell walls to allow therapies easier access to shrink tumors.
March 28, 2023
Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
October 19, 2023
The University of Cincinnati’s Timothy Phoenix is one of the investigators on a research team that is part of a new NCI Pediatric Immunotherapy Network and studying how to improve immunotherapy treatments for pediatric brain tumors.